We are live on ! Find out more
BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of BHVN yet.

BHVN Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q1 2026, worth a combined $19.7M — down 27% from $27M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BHVN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Birchview Capital, exiting entirely with an estimated $670K sold.

  • 1 institutional investor held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q1 2026, down from 2 in Q4 2025.
  • Funds reported $19.7M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q1 2026, down 27% quarter-over-quarter.
  • 0 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q1 2026 and 1 closed out, a net change of -1 holder.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. seller in Q1 2026 was Birchview Capital, an estimated $670K sold.

Based on aggregated 13F filings for Q1 2026.